Eli Lilly has reduced the prices of certain Zepbound vials and introduced higher-dose options, making the weight-loss drug ...

Eli Lilly is offering vials of its weight-loss drug Zepbound to patients at a discount — but only if they skip their ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...

Every month, roughly 100,000 people buy Zepbound directly from Eli Lilly ... vials compared to a list price of $1,086.37 per monthly injector pen. Customers can't get their health insurance ...

Novo Nordisk on Monday revealed weaker-than-expected data from a second late-stage trial of its obesity drug candidate ...

Swiss drugmaker Roche on Wednesday announced a major deal in the weight-loss category, agreeing to pay up to $5.3 billion to ...

The weight-loss drug can cost patients more than $1,000 a month if they do not have health insurance coverage.

But the LillyDirect Zepbound offer is for vials that patients ... the vials compared to a list price of $1,086.37 per monthly injector pen. Wegovy’s maker, Novo Nordisk, is charging $499 per ...

Consumers can buy Zepbound and Wegovy direct from drugmakers ... the vials compared to a list price of $1,086.37 per monthly injector pen.